Regulatory News
Tuesday, July 26, 2016
BRIEF-Inovio Pharmaceuticals doses first subject in Zika vaccine clinical trial
* Inovio Pharmaceuticals doses first subject in Zika vaccine
clinical trial
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment